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Abstract 
Sjögren, J., Bioassay-guided isolation and characterisation of antifungal metabolites -
Studies of lactic acid bacteria and propionic acid bacteria. Doctor’s dissertation. 
ISSN 1652-6880, ISBN 91-576-7016-1 
 
A bioassay-guided isolation method was developed with Aspergillus fumigatus and 
Rhodotorula mucilaginosa as target organisms. The bioassay was a dilution bioassay and 
was performed after each fractionation step. The isolation procedure was based on 
fractionation of cell-free supernatants using solid phase extraction (SPE) and reversed-
phase high performance liquid chromatography (RP-HPLC). Cell-free supernatant was 
fractionated on a C18 SPE column, and the 95% aqueous acetonitrile fraction was further 
fractionated on a preparative HPLC C18 column. Fractions active in the bioassay were 
further separated using preparative HPLC with a C18 column or a porous graphitized carbon 
column. In the second HPLC step the conditions were optimised for each active fraction. 
The method was used for analysis of cell-free supernatants from strains of lactic acid 
bacteria (LAB), propionic acid bacteria (PAB), and uninoculated sodium lactate (SL) 
medium. The structures of the isolated antifungal metabolites were characterised using 
nuclear magnetic resonance (NMR), mass spectrometry (MS) and gas chromatography-mass 
spectrometry (GC-MS). 
The studies of LAB strains resulted in the isolation and identification of several 
antifungal diketopiperazines (DKPs); cyclo(L-Leu-cis-4-OH-D-Pro), cyclo(L-Leu-trans-4-
OH-L-Pro), cyclo(L-Phe-cis-4-OH-D-Pro), cyclo(L-Phe-trans-4-OH-L-Pro) and cyclo(L-Phe-
L-Pro), and 3-hydroxy fatty acids (3-OH-FAs); (R)-3-hydroxydecanoic acid, (R)-3-
hydroxydodecanoic acid, (R)-3-hydroxytetradecanoic acid and 3-hydroxy-5-cis-dodecenoic 
acid, and D-3-phenyllactic acid (PLA) and L-3-PLA. The antifungal metabolites isolated or 
identified from dairy PAB were; cyclo(L-Phe-L-Pro) and cyclo(L-Ile-L-Pro) and D-3-PLA 
and  L-3-PLA. From SL medium, used for cultivation of dairy PAB, seven antifungal 
peptides, His-Pro-Leu-Pro-Leu, Phe-Leu-Pro-Tyr-Pro, Gly-Pro-Phe-Pro-Ile, Gly-Pro-Phe-
Pro-Leu, Gly-Pro-Phe-Pro-Leu-Val, Val-Tyr-Pro-Phe-Pro-Gly-Pro-Ile and Val-Ala-Pro-
Phe-Gly-Val-Ala-Val-Phe-Gly were isolated and characterised by FAB-MS/MS. The 
minimal inhibitory concentration (MIC) against A. fumigatus was 20 mg/ml for cyclo(L-
Phe-L-Pro) and cyclo(L-Ile-L-Pro), 25 µg/ml for 3-OH-dodecanoic acid, 100 µg/ml for 3-
OH-decanoic acid and 7.5 mg/ml for PLA. 
A high performance liquid chromatography electrospray mass spectrometry (HPLC-ES-
MS) method was developed for identification of DKPs in a complex cultivation medium. 
For determination of the absolute configuration of 3-OH-FAs a GC-MS method was 
developed. The method was based on the analysis of a 3-O-trimethylsilyl  N-(S)-
phenylethylamide derivatives of the isolated 3-OH-FAs. 
 
Keywords:  Propionibacterium,  Lactobacillus,  Pediococcus, cyclic dipeptides, antifungal 
activity, silage, yeast, mould. 
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‘Would you tell me, please, which way I ought to go from here?’ 
‘That depends a good deal on where you want to get to,’ said the Cat. 
‘I don’t much care where - ’ said Alice. 
‘Then it doesn’t matter which way you go,’ said the Cat. 
‘ – so long as I get somewhere,’ Alice added as an explanation. 
‘Oh, you’re sure to do that,’ said the Cat, ‘if you only walk long enough.’ 
 
Lewis Carroll 
”Alice’s Adventures in Wonderland” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CELEBRATE, THIS PARTYS OVER IM GOING HOME 
 
An Emotional Fish 
”Celebrate” 
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3-OH-FA   3-Hydroxy fatty acid 
APCI     Atmospheric-pressure  chemical  ionisation 
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C8     O c t y l  
C18        O c t a d e c y l  
C D       C i r c u l a r   d i c h r o i s m  
COSY   Correlation  spectroscopy 
D2O    Deuterium  oxide 
D a       D a l t o n  
DKP     Diketopiperazine 
DMSO    Dimethyl  sulfoxide 
EI     Electron  impact 
EIC      Extracted  ion  chromatogram 
E S       E l e c t r o s p r a y  
ESI      Electrospray  ionisation 
F A       F a t t y   a c i d  
FAB     Fast  atom  bombardment 
FID      Free  induction  decay 
G C       G a s   c h r o m a t o g r a p h y  
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HMBC      Heteronuclear multiple bond correlation 
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HPLC      High performance liquid chromatography 
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i.d.      Internal  diameter 
IE     Ion  exchange 
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LLE    Liquid-liquid  extraction 
MALDI    Matrix-assisted  laser  desorption/ionisation 
MeCN   Acetonitrile 
MeOH    Methanol 
MIC    Minimal  inhibitory  concentration 
MRS        de Man Rogosa Sharpe  
MS      Mass  spectrometry 
MS
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Mw       Molecular weight 
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NMR     Nuclear  magnetic  resonance 
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PGC     Porous  graphitized  carbon 
PLA    3-Phenyllactic  acid 
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SEC    Size  exclusion  chromatography 
SFC    Supercritical  fluid  chromatography 
SL      Sodium  lactate 
SPE    Solid  phase  extraction 
TFA    Trifluoroacetic  acid 
TLC    Thin  layer  chromatography 
TMS     Tetramethylsilane 
TOCSY    Total  correlation  spectroscopy 
TOF    Time-of-flight 
tR        Retention time 
U V       U l t r a   v i o l e t  
δ       C h e m i c a l   s h i f t    9
Introduction 
Fungi cause great losses in agriculture as well as in the forest and food industry. 
Different chemicals, so called fungicides, have been used to prevent and kill fungi 
in various environments. Although fungicides have been used with good results the 
drawback of using fungicides is their potential negative effects on the environment, 
for instance toxicity to humans, birds and animals, accumulation in soil and water 
and build-up of resistance in pathogen populations. Today, the public demand has 
grown for more environmental friendly methods to prevent fungal spoilage of food 
and feed. 
 
The research program Microbial Antagonism against Fungi (MAaF) started in 
1996 at the Swedish University of Agricultural Sciences and has had as its goal to 
find and characterise microorganisms that could be used for biological control of 
fungi in different areas. Microorganisms have been used in the service of mankind 
for thousands of years, e.g. the Sumerians used fermentation as early as 2000 B.C. 
to make beer and the Egyptians used lactic acid bacteria (LAB) for preservation of 
milk (1). The discovery of penicillin from Penicillium mould by Fleming in 1928 
has had a huge impact on the health of man, and the start of industrial production 
of penicillin in the 1940’s has indeed shown to what extent mankind can make use 
of microorganisms. In 1981 Demain (2) predicted, as a result of the revolutionary 
developments in molecular genetics, that industrial microbiology had the potential 
to solve major world problems. Twenty-four years later the field still has this great 
potential and we are just beginning to learn how to utilise the vast natural resources 
that microorganisms are. Perlman (3) has stated: (i) the microorganism is always 
right, your friend, and a sensitive partner; (ii) there are no stupid microorganisms; 
(iii) microorganisms can and will do anything; (iv) microorganisms are smarter, 
wiser, more energetic than chemists, engineers, and others; and (v) if you take care 
of your microbial friends, they will take care of your future. A lot has happened in 
this field during the last two decades, but one explanation to why we have not yet 
solved major world problems with the aid of microorganisms is that it is very 
difficult to master and to study microorganisms. Today, it is estimated that less 
than 1% of the soil microorganisms can be cultivated in the laboratory (4). We also 
have the ethical aspects (5, 6), for instance, should we be allowed to genetically 
modify microorganisms? In the MAaF program we have not worked with 
genetically modified microorganisms, since we think that many microorganisms 
have the potential to be used without genetic modifications. 
 
Phoebe et al  (7) investigated 217 extremophilic microorganisms in their search 
for antifungal metabolites and the antifungal metabolite, pyochelin, was isolated 
and characterised. Bode et al  ( 8) varied the growth conditions for the 
microorganism to increase the number of secondary metabolites from one 
microbial source. We have chosen a another way in the search for microorganisms 
with antifungal properties for use in different feed and crop systems. We went 
looking for nice, friendly and omnipresent bacteria (II). We focused on LAB and 
propionic acid bacteria (PAB). Both of these groups of bacteria have a long history 
of use in the preservation of food and feed. We have all probably eaten them  10
several times, since they are present in cheese, yoghurt, sour milk and on fruits. To 
be able to create a good preservation system by applying microorganisms, we 
believe that the microorganisms should be isolated from the environment where 
they are suppose to be used. The microorganisms should furthermore be harmless 
to humans and animals. Most importantly, their antifungal metabolites, mode of 
action and possible usefulness, e.g. in silage systems, have to be studied and 
investigated. This thesis is a part of that investigation and is focused on antifungal 
metabolites produced by LAB and PAB. 
 
 
Aims 
The goal of this thesis was to isolate antifungal metabolites from LAB and PAB by 
using bioassay-guided isolation and elucidate their structures. To achieve this goal 
strains of LAB and PAB had to be selected, and methods for isolation, 
identification, and absolute configuration determination of metabolites had to be 
developed during the process. The uninoculated cultivation media for LAB and 
PAB, de Man Rogosa Sharpe (MRS) broth and sodium lactate (SL) broth, were 
also investigated to verify that the isolated antifungal metabolites originated from 
the bacteria.  
 
The specific objectives of this thesis were: 
 
•  Develop a bioassay-guided isolation protocol (I). 
•  Isolate and characterise antifungal metabolites from LAB (I–III, 
unpublished results). 
•  Isolate and characterise antifungal metabolites from dairy 
propionibacteria (IV). 
•  Develop a method for identification of diketopiperazines (DKPs) in MRS 
broth (unpublished result). 
•  Develop a method for determination of the absolute configuration of 3-
hydroxy fatty acids (unpublished results). 
•  Investigate the SL medium used for cultivation of dairy propionibacteria 
(V). 
 
The literature survey in this thesis, has, as much as possible, been focused on 
recent publications and has, in the chapters covering the analytical techniques used 
in this thesis, also focused on review articles. 
 
 
Lactic acid bacteria 
The general description of LAB states that LAB are bacteria that produce lactic 
acid as the principal or sole end product of sugar fermentation. They are also   11
described as Gram
1-positive, non-sporulating and rod- or cocci-shaped bacteria. 
Lactic acid bacteria inhabit nutrition rich environments, such as humans, animals, 
food and plants (9). At present, around 20 different genera are included in the 
group of LAB (10). 
 
Lactic acid bacteria are aerotolerant anaerobes used for the conservation and 
production of milk products, sausages, sauerkraut and feed. Lactic acid bacteria 
naturally occur on plants and grass used for fodder and have for a long time been 
recognised as a natural preservative of silage. Lactic acid bacteria have also been 
studied for their use as preservatives in food (1) and the antifungal activity of LAB 
has recently been reviewed by Batish et al (11) and Schnürer & Magnusson (12). 
Lactic acid bacteria have GRAS (generally recognised as safe) status, which means 
they are regarded as harmless to humans. There are also reports indicating that 
LAB could have beneficial properties for human health, so called probiotic effects, 
however the results are inconsistent (13, 14). LAB in silage may also have 
beneficial effects on animal performance (15). 
 
In paper II over 1200 isolates of LAB were isolated and screened against 
Aspergillus fumigatus. The different strains of LAB were mostly isolated from 
plant materials such as leaves, stems and flowers. In Table 1 presents the LAB 
species studied in this thesis together with their source of isolation. 
 
Table 1. Source of isolation, species identity of Lactobacillus and Pediococcus strains 
studied in this thesis 
 
Strain Species  Source  Reference 
MiLAB 6  L. plantarum  Lilac flowers  II 
MiLAB 14  L. plantarum  Lilac flowers  II, III 
MiLAB 16  P. pentosaceus  Chestnut flowers  II 
MiLAB 24  P. pentosaceus  Clover II 
MiLAB 91  L. sakei  Dandelion II 
MiLAB 170  P. pentosaceus  Grass II 
MiLAB 393  L. plantarum  Grass
a I 
Si3  L. coryniformis  Grass II 
aGrass silage, two sorts of grass and <20% clover 
 
 
Propionic acid bacteria 
Propionic acid bacteria include several genera, which are quite different and found 
in different environments; on skin, in soil or in food. In this thesis we have worked 
with dairy propionibacteria. Propionibacteria are known for their ability to produce 
propionic acid from lactic acid and their production of CO2, responsible for the 
holes in certain cheese types, e.g. Emmentaler (16). They can also produce acetic 
acid and vitamin B12 ( 16) and it has been reported that PAB can produce 
                                                            
1 Hans Gram, Danish physician who developed a test to distinguish between bacteria with a 
single thick cell wall (Gram-positive) and bacteria with thin layers as cell wall (Gram-
negative).  12
bacteriocins
2 ( 17). Propionibacteria  are slow growing, non-sporulating, Gram-
positive, anaerobic bacteria, i.e. they are very similar to LAB. The major difference 
is that LAB usually grow faster than PAB and this can be a problem when trying to 
isolate PAB in the presence of LAB. Propionic acid bacteria can be rod-shaped or 
branched and can occur singularly, in pairs, or in groups. 
 
The probiotic properties of PAB have been investigated (18), and as for LAB, 
the results cannot clearly prove that PAB are beneficial to the health. However, 
there are indications in favour of using PAB as probiotics (19). Propionic acid 
bacteria have been studied as biopresevatives in fermented milk and bread (20) and 
in silage (21). 
For our study of propionibacteria we chose the type strains of five different dairy 
propionibacteria species, which were Propionibacterium jensenii, P. thoenii, P. 
acidipropionici, P. freudenreichii subsp. shermanii and P. freudenreichii subsp. 
freudenreichii (IV, V). 
 
 
Isolation of antifungal metabolites 
Bioassay 
The bioassay plays a very important part in natural products chemistry research 
and in this thesis. There are some criteria that the bioassay should fulfil: 
 
1.  Relevant target organism/organisms. 
2.  Reliable and reproducible results. 
3. Sensitive. 
4. Fast. 
5. Simple. 
6.  Standardized detection method, preferably an instrumental method. 
 
All of the parameters above should be considered when developing or selecting a 
bioassay. Especially important is the choice of target organism. The target 
organism determines which kind of compounds that will be detected and later on, 
isolated. Therefore, to be able to isolate as many compounds as possible it is best 
to use several target organisms or to use an organism that is sensitive to many 
different compounds. Generally, the limiting factor in isolation of natural products 
is the small amount of test materials available for bioassay and structure analysis. 
Using several organisms during the isolation procedure requires more material than 
using one organism. So, usually a compromise between time, target organisms and 
amount of isolated material given to bioassay has to be done. 
 
In general, bioassays can be divided into either diffusion or dilution methods. In 
a diffusion assay, e.g. the dual-culture overlay assay (22, II), TLC bioautographic 
assay (23) or disk diffusion method (24), the active compound has to diffuse into a 
                                                            
2 Peptides or proteins that kill bacteria of another strain or species.   13
medium containing a target organism. In diffusion assays there can be a problem 
for the active metabolite to diffuse into the medium, and as a result no inhibition is 
detected. In a dilution bioassay, e.g. the microtiter well plate assay (22, I-V), the 
same problem does not arise because the metabolite and the target organism are 
both dissolved in the medium. Instead, solubility problems of the active 
compounds can occur, however this can be avoided by using a detergent, at a non 
inhibitory concentration, in the liquid medium (25). Hadacek & Greger (26) 
conducted a comparison between several antifungal bioassays, both diffusion and 
dilution assays, and concluded that a microdilution method has the greatest 
potential to become a standard method in the future. 
 
In this thesis both a diffusion and dilution assay have been used (I-V). The dual-
culture overlay assay has been used for the screening of LAB for their antifungal 
activity (II). In the diffusion bioassay the LAB were screened against five mould 
species,  Aspergillus fumigatus,  Aspergillus nidulans,  Penicillium commune, 
Penicillium roqueforti and Fusarium sporotrichioides and three yeasts species, 
Rhodotorula mucilaginosa,  Pichia anomala and Kluyveromyces marxianus. All 
fungi were selected to represent economically important spoilage organisms in the 
production of food and feed (27). Based on the findings in paper II interesting 
LAB strains could be selected for further studies of their antifungal activity (I-III). 
The microtitre plate well assay was used to follow the antifungal activity during 
isolation of antifungal metabolites in this thesis (I-V). A. fumigatus was chosen as 
the target organism due to its sensitivity to different LAB strains (II). In paper V R. 
mucilaginosa was added as a target organism to study if any differences in the 
activity pattern, using two target organisms, could be detected between three of the 
investigated propionibacteria. For determination of minimal inhibitory 
concentration (MIC) the microtitre plate well assay was used (I). 
 
Sample preparation 
Isolation of metabolites from plants, animals or microorganisms can be achieved in 
several ways, but most of them need a sample preparation step. Sample preparation 
has to be applied before the separation step, which usually is a chromatographic 
technique, to prevent the equipment from being clogged, contaminated or 
damaged. 
 
The two main purposes of the sample preparation are isolation and enrichment. 
In the isolation part the purpose is to separate the analytes of interest from the 
matrix and an enrichment of the analytes is often necessary, to achieve a good 
result later in the detection step. The problem is to avoid removing active 
metabolites. This is very difficult to achieve when you perform a blind isolation, 
i.e. you don’t know what kind of compound or compounds you want to isolate. 
Ways to achieve this is to use complementary methods or a general method. 
Traditionally, liquid-liquid extraction (LLE) has been used for sample 
preparation in natural product research. Liquid-liquid extraction refers to a transfer 
of a solute from one liquid phase to another, e.g. metabolites from a culture 
supernatant to an organic solvent. Hydrophobic compounds are transferred to the 
organic solvent and water soluble compounds stay in the water phase. Liquid-liquid  14
extraction is a mature and robust method, however there are some drawbacks such 
as; it is time consuming, large amounts of hazardous organic solvents are used and 
it is very difficult to automate. Recently an automated LLE system has been 
described (28), but automation of LLE is still not a matter of routine. Probably the 
biggest disadvantage with LLE is that it is not suitable for reversed-phase liquid 
chromatography (RP-LC) without further reprocessing of the samples. For the 
interested reader I can recommend the article by Pawliszyn (29) and the reviews by 
Gilar et al (30) and Raynie (31). All three papers present a broader perspective and 
more fundamental aspects of sample preparation. 
 
Solid phase extraction 
Solid phase extraction (SPE) is a sample preparation technique that has been 
growing in popularity during the last 20 years. Today, SPE is the most frequently 
used sample preparation technique, mainly because SPE is easily automated (32), 
has a wide range of applications, has high reproducibility and consumes low 
amounts of organic solvents (33). Solid phase extraction is very similar to LC but 
has a much lower chromatographic efficiency, less than 60 plates vs. more than 10 
000 plates for HPLC (30). Solid phase extraction can be divided into four groups; 
reversed-phase (RP), normal-phase (NP), ion exchange (IE) and adsorption SPE. I 
will concentrate on RP-SPE, since this is the method I have applied in papers I-V. 
In RP-SPE, octadecyl-bonded silica (ODS or more common C18) is the most used 
and general material, see Fig. 1. Other materials that are used are graphitized 
carbon, useful both in RP and NP, octyl-(C8) or phenyl-bonded silica, and porous 
polymers. The material is usually packed in a disposal cartridge. 
 
Fig. 1. Schematic view of an octadecyl-bonded silica particle. 
 
For a more thorough survey of modern SPE materials, applications and coupling 
to high performance liquid chromatography (HPLC), see the reviews by Pyrzynska 
(34), Rawa-Adkonis et al (35) and Hennion (36). 
 
The principle of SPE is that the analyte is trapped in the sorbent and thereafter 
desorbed and eluted with a small portion of organic solvent (37). Solid phase 
extraction has been found to be very useful in sample preparation of 
environmental, food, biomedical and biological samples. In isolation of natural 
products from plants, LLE is still the most preferred method in isolation of 
metabolites (38). Solid phase extraction can be a non-specific method and a wide 
range of compounds can be isolated using one sorbent material. But, if LLE would 
be used for isolation of a wide range of compounds with different hydrophobicity, 
Silica particle
O
Si
O
Si
OH
OH
O
Si  15
charge etc, then several solvents would need to be used. This can be an advantage 
when using LLE for isolation of known metabolites or certain types of compounds. 
 
In our studies we wanted a fast, easy, non-hazardous, RP-HPLC compatible and 
general method, and therefore we used SPE in the sample preparation step. 
In papers I-V the SPE method for sample preparation was based on disposable 70-
ml cartridges packed with 10 g end-capped C18 sorbent. The method involved five 
steps: 
 
1.  Activation of SPE material with 30 ml of MeCN. 
2.  Equilibration with 30 ml MilliQ-water. The rule is to use the same solvent 
composition as in the sample. 
3.  Sample loading, maximum of 400 ml/10 g cartridge. 
4.  Washing with 30 ml of 5% aqueous MeCN, to remove hydrophilic 
compounds, usually salts, amino acids and carbohydrates originating from 
the growth medium. 
5.  Elution with 30 ml 95% aqueous MeCN. 
 
For screening of the antifungal activity of different bacteria, 200 ml of cell-free 
supernatant was used and for isolation up to 5 l was used. The sample now 
consisted of two fractions, one hydrophilic, from step 3 and 4 above, and one 
hydrophobic, from step 5. Both fractions could now be subjected to bioassay, but 
the hydrophilic fraction would either contain antifungal lactic acid or antifungal 
propionic acid, depending on which organism was studied. Therefore only the 
hydrophobic fraction was lyophilized and subjected to bioassay. This bioassay step 
was later omitted, since it was shown that the antifungal metabolite lactic acid also 
was present in this fraction (II). 
 
Investigation of the hydrophilic fraction from Lactobacillus plantarum MiLAB 
393 resulted only in isolation of the amino acid arginine (large amount) and lactic 
acid (unpublished results). The hydrophilic fraction was fractionated using 
preparative size exclusion chromatography (SEC) and then investigated with the 
methodology that will be described below. The SEC step was very time consuming 
and labour intense. Due to the fact that we had isolated over 50 interesting active 
LAB strains in paper II, the rest of the work in this thesis was focused on isolation 
of antifungal metabolites from the hydrophobic fraction. 
 
Separation 
In a sample with a complex matrix, a separation step is usually needed before the 
bioassay, structure elucidation, or identification of metabolites. Chromatography, 
the most used separation technique, has had a huge impact in the field of separation 
science since it was developed in 1903 by the Russian botanist Michail Tswett 
(39). In chromatography, the separation is based on the analytes distribution 
between a stationary and a mobile phase. Based on the differences in the mobile 
phase, chromatography is classified into three categories; liquid chromatography, 
gas chromatography (GC) and supercritical fluid chromatography (SFC). 
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Liquid chromatography 
Liquid chromatography is divided into five different categories based on what kind 
of interaction mechanism the analyte has with the stationary phase; adsorption 
chromatography (liquid-solid chromatography), partition chromatography (liquid-
liquid chromatography), size exclusion chromatography, ion-exchange 
chromatography (IEC) and affinity chromatography. 
The power of LC lies in its broad range of compounds that can be separated and its 
capability of separating water based samples. This makes LC very suitable for 
separation of compounds in biological systems. The most common method of LC 
is RP-LC, where the stationary phase is more hydrophobic than the mobile phase. 
The stationary phase is often C18 chains bound to small porous silica particles as 
illustrated in Fig. 1. Mobile phases are often water based buffers together with an 
organic modifier like MeCN or MeOH. When a more hydrophilic stationary phase 
than the mobile phase is used then it is called normal-phase (NP) LC. The names 
NP and RP have historical reasons. At the time when LC was being developed, 
most of the work was performed with more hydrophilic stationary phases than the 
mobile phase. That was the normal condition, hence the name NP chromatography. 
Today, the opposite is true for analytical applications and RP-HPLC is the 
workhorse in most modern laboratories. In preparative applications NP-LC is still 
widely used, mainly for economical and practical reasons. 
 
The flow of the mobile phase was originally achieved by gravity, but in the 
1960´s, the mobile phase was being pumped through the column. To make it 
possible to distinguish between the two different methods of LC, the new method 
was called high pressure liquid chromatography. Today the abbreviation HPLC 
stands for high performance liquid chromatography. I will not go into a detailed 
discussion of the retention mechanism in RP-HPLC, but for an in depth study I 
recommend the book by Snyder & Kirkland (40) or more recent reviews (41, 42). 
An LC method that is widely used in natural products research is thin layer 
chromatography (TLC). It is a simple, easy, low-tech and low-cost method, but the 
separation capacity of TLC is rather limited compared to HPLC (40). 
 
I have only used RP-HPLC in all papers so when I refer to HPLC, I mean RP-
HPLC. In papers I-IV isolation of antifungal metabolites was performed using 
multidimensional chromatography (41). In multidimensional chromatography, two 
HPLC columns with distinct differences in retention mechanism are used. In the 
first HPLC step a C18 column was used and in the second step a porous graphitized 
carbon (PGC) column. Before the second HPLC separation, a method development 
was conducted to find the optimal conditions for the separation of each active 
fraction. Optimisation of an HPLC separation can be achieved by varying the 
mobile phase (components or composition), column type (C18, C8, phenyl, 
graphitized carbon) or temperature (43, 44). Changing the composition (the 
percentage of solvents) of the mobile phase is usually the simplest thing to start 
with, however the change in selectivity is not so great. A change in mobile phase 
components will have a bigger effect on the selectivity, but is also more time 
consuming. We wanted a method that was compatible both with liquid   17
chromatography mass spectrometry (LC-MS) and nuclear magnetic resonance 
(NMR), and this narrowed down the selection of mobile phases that could be 
utilised. No involatile buffers could be used, however volatile additives such as 
formic acid, trifluoroacetic acid (TFA), ammonia or diethylamine could be used to 
vary the pH of the mobile phase or to have an ion-pairing effect. Trifluoroacetic 
acid has ion-pair properties, which can improve the separation in HPLC, especially 
for peptides and proteins (45). A problem when using TFA in HPLC electrospray 
ionisation mass spectrometry (ESI-MS) is that the ionisation could be decreased by 
30-80% compared to using formic acid (46). In papers I-IV, TFA has been used in 
the second HPLC step. In paper V formic acid has been used. An effective way to 
improve the separation of similar compounds, is to use isocratic elution instead of 
gradient elution. In the second HPLC step an isocratic elution was used in papers I-
V for separation of the analytes. To alter the selectivity of the separation another 
column can be used, and this can be a more powerful way of changing selectivity 
than changing mobile phase composition (43, 47). We have used a porous 
graphitized carbon column in the second separation step in papers I-IV. The PGC 
column can be used both for RP- and NP-HPLC, in the entire pH range and has a 
stronger hydrophobicity than C18 (48). Due to the strong hydrophobicity of PGC, 
very polar compounds can be separated using reversed-phase conditions, and this 
can be difficult using a C18 column (49). The temperature influences retention, 
system pressure, selectivity and column stability (40, 43). Snyder & Kirkland 
stated in their book that changing the temperature had little effect on selectivity 
(40). But today, temperature is recognized as a useful parameter in changing the 
selectivity in HPLC (50, 51). A change in the temperature is achieved more easily 
than changing the solvents or the column. In the optimisation of the second HPLC 
different temperatures, from 20 to 50 °C, were evaluated, however it usually had 
little effect on the selectivity. Therefore, the separations in papers I-V were all 
conducted at room temperature, 20–22 °C. The exceptions were in the HPLC-ESI-
MS analysis in paper V where the temperature was 35 °C, and for the HPLC-ESI-
MS method for identification of DKPs where 50 °C was used (unpublished 
results). 
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Fig. 2. HPLC chromatogram from analysis of cell-free supernatant of Pedicoccus 
pentosaceus MiLAB 170 using a Discovery C18 column (100 ×  21.2 mm i.d.), flow 10 
ml/min, UV detection 210 nm, linear gradient 5% MeCN to 100% MeCN in 10 min, 5 min 
at 100 % MeCN. Lactic acid and fractions 31-33 had activity against Aspergillus fumigatus 
in the bioassay. 
 
For isolation of antifungal compounds a crude separation was first achieved 
using a C18 column and a steep, linear gradient from 5% aqueous MeCN to 100% 
MeCN in 10 minutes. A preparative C18 column was used for the fractionation and 
90 mg lyophilized material from the SPE was injected. All analyses were 
monitored using an ultraviolet (UV) detector at 210 nm. Fig. 2 shows the 
chromatogram of cell-free supernatant from P. pentosaceus MiLAB 170 after the 
SPE. All fractions were collected in a 96 2-ml deep-well plate using a fraction 
collector. Before bioassay the fractions were dried using a water bath at 40 °C and 
a gentle stream of air blowing through each well. About 1 g of material was 
received in the SPE step from 2 l of cell-free supernatant. This material was 
subsequently injected and fractionated in the first HPLC step. In papers IV and V 
the same procedure as above was used but with a slight modification. The gradient 
was 5% aqueous MeCN to 95% MeCN in 10 minutes. The result of the bioassay, a 
spore germination assay, after the first HPLC of cell-free supernatant from P. 
pentosaceus MiLAB 170 is shown in Fig. 3.  
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Fig. 3. Bioassay against Aspergillus fumigatus of fractions collected after the first HPLC 
step from fractionation of cell-free supernatant from Pediococcus pentosaceus MiLAB 170. 
Arrows indicating the direction of collection. Active fractions were 12–15 (lactic acid) and 
fractions 31–33 (Fig. 2). 
 
After identification of the active fractions, the same fractions from different 
HPLC runs were pooled together and dried in a vacuum centrifuge. Each active 
fraction from the first HPLC contained several different compounds as illustrated 
by the chromatogram after the second HPLC step of fraction 31-33 (Fig. 4). 
 
We have developed a protocol for the method development in the second HPLC 
step: 
 
1.  Change column from C18 to PGC. 
2.  Add 0.1% formic acid or 0.1% TFA to the mobile phase. 
3.  Find isocratic condition for optimal resolution. 
4.  Vary the temperature. 
 
Leira et al (52) have previously described a column-switching HPLC method 
where they used an C18 column coupled to a PGC to separate a complex mixture of 
non-flavonoid polyphenols. The methodology has also been applied for isolation of 
active constituents in natural materials (53).  
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Fig. 4. HPLC chromatogram of fractions 31-33 (10 mg) from P. pentosaceus MiLAB 170. 
The separation was conducted using a porous graphitized carbon column (100 ×  21.2 mm 
i.d.) equipped with a guard column (10 ×  10 mm i.d.), flow 10 ml/min, UV detection 210 
nm, isocratic condition 30% MeCN and 70% water with 0.1% trifluoroacetic acid 
(unpublished results). Identified antifungal metabolites are indicated in the chromatogram. 
 
In paper V, a good separation could not be achieved with the PGC column, 
instead a C18 column was also used for the second HPLC step. The separation was 
better but still not all peptides could be separated. TFA was tested as an ion-pairing 
reagent, but the separation was better with formic acid. 
A very powerful method that was not used in this thesis, which really can shorten 
optimisation time in HPLC, is computer simulation. Only after performing a few 
HPLC experiments, the software can calculate the optimal conditions for a specific 
separation (54, 55). 
 
 
Structure elucidation 
What is needed for a successful structure elucidation when an active metabolite has 
been isolated in pure form? What are the problems that have to be solved? 
Insufficient amounts of material is almost always a problem in the isolation of 
natural products. Has enough material been isolated for a complete structure 
elucidation? Usually, this is seldom known in advance, and a reisolation of the 
active compound is often necessary for the structure elucidation. Hence, it is 
important to have a reproducible method for the isolation of compounds. 
A molecular formula, a structural formula and an absolute configuration of the 
isolated metabolite should be provided for a full structural characterisation. This is 
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illustrated in Fig. 5 using cyclo(L-Leu-trans-4-OH-L-Pro) isolated from P. 
pentosaceus MiLAB 170 (unpublished results) as an example. 
 
 
Fig. 5. Cyclo(L-Leu-trans-4-OH-L-Pro) isolated from Pediococcus pentosaceus MiLAB 
170 (unpublished results). 
 
According to Hanson (56) the structure elucidation of natural products can be 
divided into four stages: 
 
1. Preliminary characterisation. Determination of physical constants, 
molecular weight and identification of functional groups. 
2.  Structural simplification. Identification of carbon skeleton. 
3.  Relative stereochemistry. Position of functional groups and their relative 
configuration in space. 
4. Absolute  configuration. 
 
Table 2 summarises different techniques that can be used to achieve structural 
information without reference compound or chemical modification. A combination 
of several techniques is often needed for structure elucidation of an unknown 
compound. Sometimes this is not enough and chemical modification, e.g. 
derivatisation, hydrolysis, degradation or oxidation of the sample has to be done to 
achieve structural information. 
 
To verify that a correct structure has been assigned to a compound, a 
confirmation of the structure has to be performed. This can be done by comparing 
NMR data of the isolated compound with literature NMR data or with NMR data 
from synthesised or purchased compound. 
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Table 2. Summary of the structural information that can be achieved from different 
techniques without reference compounds 
 
Technique   Structural information 
IR, NMR, UV   Functional groups 
MS
n, NMR  Building  blocks  or repeating units (e.g. 
amino acids or carbohydrates), structural 
formula 
MS  Molecular weight, elemental composition 
NMR Relative  stereochemistry 
Circular dichroism, specific optical 
rotation 
Absolute configuration 
X-ray crystallography (compound must 
crystallize) 
Structure with absolute configuration 
 
A powerful method in the structure elucidation of natural products is to couple 
HPLC, MS and NMR. Pullen et al  were the first to construct a hyphenated 
method, which coupled HPLC-NMR-MS for analysis of a mixture (57). During the 
last decade there have been several publications using coupled HPLC-MS-NMR 
for analysis of mixtures of natural products (58-65), pharmaceuticals (62, 66, 67), 
environmental samples (68) and drug metabolites in biological fluids (62, 69). 
HPLC-NMR-MS in natural product research is a fast and powerful method that 
provides lots of structural information. HPLC-NMR-MS can be used at an early 
stage for identification of known compounds before bioassay-guided fractionation 
starts, so called dereplication (63). There are several operational conflicts to 
overcome when coupling HPLC with NMR and MS, such as solvent compatibility, 
instrumental sensitivity and magnetic field effects (70). However, the major 
obstacles for most research groups is probably the price of this hyphenated 
instrumentation, location and the expertise needed for operating. 
 
In this thesis off-line HPLC, NMR and MS experiments have been performed. 
After separation by HPLC the pure compounds are submitted to NMR and MS 
experiments for structure elucidation. The isolated compounds in this thesis have 
mainly been identified using NMR experiments in combination with MS 
experiments (I-IV). In many cases the information from NMR or MS alone is 
sufficient to elucidate the structure, but in some cases a combination is needed to 
solve the structure without available standards. From NMR a general skeletal 
structure was elucidated based on arranging the carbon and hydrogen atoms 
together with functional groups. By using the molecular weight from MS analysis 
together with the structural skeleton from NMR, the structures of the unknown 
metabolites could be determined. In paper V, the structures of the peptides from 
PAB were determined using FAB-MS/MS, because the structures could not be 
elucidated by NMR, mainly because the HPLC separation was insufficient to 
separate the peptides. For determination of the sequence of a peptide, MS methods 
or an HPLC peptide analysator are much more suitable methods than NMR (71, 
72). 
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Nuclear magnetic resonance spectroscopy 
Nuclear magnetic resonance was first discovered in 1946 (73, 74). Today, NMR is 
recognized as the most all-round and informative spectroscopic technique available 
to a chemist. It was in the 1960´s and 1970´s that the development of NMR really 
took a huge step forward when superconducting magnets, computers and the 
Fourier transform technique were introduced (75). The progress and importance of 
NMR spectroscopy has kept on growing ever since. The main use of NMR 
spectroscopy is in the determination of unknown structures, but it can also be used 
for interaction studies (76), chemical exchange experiments (77), imaging (78), 
and as an HPLC detector (79-80). 
 
In NMR spectroscopy the molecular structure is studied by measuring the 
interaction of a radio-frequency (rf) generated oscillating electromagnetic field 
with a nucleus inside a strong magnetic field. The theory in brief is (77, 82): atoms 
that have a nucleus with a nuclear spin (I) (the most important is 
1H and 
13C) are 
studied. These atoms can be oriented in 2I + 1 ways in the presence of a strong 
magnetic field (behaving like a bar magnet) and there are also 2I + 1 possible 
energy states. When the nuclear spin is ½, as for 
1H and 
13C, there are two possible 
energy levels that the nucleus can adopt. There is a population excess in the lower 
energy state, which gives rise to a net magnetisation in the applied magnetic field, 
illustrated in Fig. 6a. When a strong rf pulse is applied to the system the pulse 
equalises the population difference between the two energy levels, hence no net 
magnetisation in the z plane remains (Fig. 6b). When the pulse is over, a signal 
called the free induction decay (FID) can be picked up and thereafter transformed 
into a spectrum. 
 
 
Fig. 6. Vector model of NMR. a) Magnetisation vector (M0) at equilibrium due to the 
excess of spins in the low energy state. b) M0 after a 90°x pulse. 
 
A spectrum according to the description above, would consist of one line from 
13C and one from 
1H, depending on which nucleus is studied, which would not be 
very useful in the determination of a structure. However, the nuclei in a molecule 
experience a magnetic field that is less than the applied magnetic field, i.e. the 
nuclei are shielded. This shielding originates from the electronic and magnetic 
environment in the neighbourhood of each nucleus. Therefore all nuclei, if they 
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experience different electronic and magnetic surroundings, will have different 
signals depending on where they are located in the molecule. The signal in NMR is 
expressed as chemical shift (δ), which is defined as: 
 
δ = (sample [Hz] – TMS [Hz])/operating frequency (Hz) 
 
where tetramethylsilane (TMS) is a reference compound. The chemical shift has no 
unit. It is expressed as parts per million (ppm). By using an internal standard the 
chemical shift becomes instrument independent, which makes it easy to compare 
results with literature data, if all other sample parameters are the same. 
 
The sensitivity has generally been regarded as a problem in NMR. The low 
sensitivity is due to the small energy gap between ground and excited state and the 
low population difference between the energy states. The kind of nucleus that is 
studied also effects the sensitivity, e.g. 
1H NMR is about 5700 times more sensitive 
than 
13C (83). The sensitivity of 
13C studies has been greatly enhanced by using 
different indirect detection NMR experiments, see below. To improve the 
sensitivity in NMR stronger superconducting magnets (84), cold probes (85-88) 
and small sample volumes (89-91) have been used. Today, a sample amount of 
<100 µg, for small molecules Mw <1000 Da (100 nmol), is sufficient for structural 
elucidation using NMR. For structure elucidation different NMR experiments are 
used, and Reynolds & Enríquez (92) discussed in their review how to choose the 
best pulse sequences, acquisition parameters, processing and probes for structure 
elucidation of natural products. 
 
The NMR experiments, which were used for the structure elucidation of 
antifungal metabolites presented in this thesis and in papers I-V, were one 
dimensional 
1H, two-dimensional 
1H-
1H correlation spectroscopy (COSY, 93), 
1H-
1H total correlation spectroscopy (TOCSY, 94), 
1H-
13C heteronuclear multiple 
bond correlation (HMBC, 95) and 
1H-
13C heteronuclear multiple quantum 
coherence (HMQC, 96) or 
1H-
13C heteronuclear single quantum coherence 
experiments (HSQC, 97). The most useful information from each different NMR 
experiment, used in structure elucidation of isolated compounds, is summarised in 
Table 3. When possible, HSQC should be used instead of HMQC due to higher 
sensitivity (98-99). All experiments were recorded at 30 °C using dimethyl 
sulfoxide-d6 (DMSO), D2O, CD3OD or CDCl3 as solvents. The experiments were 
performed according to Bruker standard pulse sequences. Proton chemical shifts 
were determined from one-dimensional 
1H NMR and from HSQC or HMQC 
experiments and 
13C chemical shifts were determined from HSQC or HMQC and 
HMBC experiments. 
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Table 3. The structural information that can be achieved from various NMR experiments 
used in this thesis 
 
NMR experiment  Information 
1H  Identification of kind of protons, number of non-
exchangeable protons.  
COSY  Identification of protons close together (separated by 
2 or 3 bonds). 
TOCSY  Identification of spin systems. 
HSQC or HMQC  Identification  of  connected  proton-carbon,  CH2 
identification, what kind of carbon. 
HMBC  Identification of connected proton-carbon by 2 or 3 
bonds, carbons without attached proton. 
 
By using the different NMR experiments on an isolated compound the 
1H and 
13C signals were assigned. First the number of non-exchangeable protons and 
functional groups were determined, and then, by using the data from 
COSY/TOCSY, different pieces (spin systems) of the molecule were linked 
together. From HSQC or HMQC the carbons were determined and with the aid of 
the data from HMBC the spin systems could be linked and a structure emerged. 
The NMR data was compared with data from commercially available compounds 
or from literature. 
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Fig. 7. 
1H-
1H COSY spectrum of 3-hydroxy-5-cis-dodecenoic acid, CDCl3 used as solvent, 
temperature 30 °C, 600 MHz instrument equipped with a 2.5 mm microprobe, 64 scans 
(III). 
 
In Fig. 7 the 
1H-
1H COSY spectrum illustrates the 
1H-
1H couplings in 3-hydroxy-
5-cis-dodecenoic acid, which was isolated from L. plantarum MiLAB 14 (III). 
Only 300 µg was used for the structure elucidation and the HSQC spectrum, which 
was used for the assignment of the carbons in the molecule, is shown in Fig. 8.  26
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Fig. 8. HSQC spectrum of 3-hydroxy-5-cis-dodecenoic acid, CDCl3 used as solvent, 
temperature 30 °C, 600 MHz instrument equipped with a 2.5 mm microprobe, 64 scans 
(III). 
 
Determination of the configuration of the double bond was achieved by using the 
coupling constant 
3JH5,H6. The literature data for cis 
3JH,H is 0-12, typical value of 8, 
and for trans 
3JH,H is 12-18, typical value of 15 (100). The value for 3-hydroxy-5-
cis-dodecenoic acid was about 10, which was in agreement with data from the 
literature on the same compound (101). Furthermore, the signal of the methylene 
carbon adjacent to the double bond (C-7) had δ 27.5, which is in agreement with 
literature data, δ 27.3, when adjacent to a cis double bond (102). A methylene 
carbon, adjacent to a trans double bond, should have δ 32.7 (102). Hence, it was 
concluded that the double bond had the cis configuration. 
The 
1H chemical shift data from cyclo(L-Leu-trans-4-OH-L-Pro) and cyclo(L-Leu-
cis-4-OH-D-Pro) isolated from P. pentosaceus MiLAB 170 are presented in Table 
4 (unpublished results). The compounds only differ in the absolute configuration of 
one of the amino acids, but their 
1H NMR spectra are fairly different. The signals 
that differ the most are signals from H-3, H-8, H-9, H-10 (one of them) and H-11. 
The difference in chemical shift between the protons in the two molecules is due to 
the different absolute configuration of the proline residue. In cyclo(L-Leu-cis-4-
OH-D-Pro) H-3 gets more shielded, which means that it has a higher electron 
density, compared to H-3 in cyclo(L-Leu-trans-4-OH-L-Pro). This effect is 
responsible for the lower chemical shift of the H-3 signal in cyclo(L-Leu-cis-4-OH-
D-Pro).  
   27
 
Table 4. 
1H Chemical shifts for cyclo(L-Leu-trans-4-OH-L-Pro) and cyclo(L-Leu-cis-4-OH-
D-Pro) isolated from Pediococcus. pentosaceus MiLAB 170 (unpublished results), solvent 
CD3OD, temperature 30 °C, 600 MHz instrument 
 
Proton Cyclo(L-Leu-trans-4-OH-L-Pro)   Cyclo(L-Leu-cis-4-OH-D-Pro) 
H-3 4.17  3.88 
H-6 3.46 
3.66 
3.43 
3.67 
H-7 4.46  4.40 
H-8 2.09 
2.27 
2.20 
2.50 
H-9 4.54  4.30 
H-10 1.52 
1.93 
1.56 
1.66 
H-11 1.90  1.78 
H-12 0.90 
1.00 
0.90 
1.00 
 
An even more profound effect can be seen when the 
1H NMR spectra from 
cyclo(L-Phe-cis-4-OH-D-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) are compared, 
see Fig. 9. The phenyl ring has a great impact on the chemical shift on H-9 in 
cyclo(L-Phe-cis-4-OH-D-Pro). The difference in chemical shift for H-9 in the two 
compounds is 1.5 ppm. The chemical shift for H-9 is δ 4.3 (DMSO-d6) in cyclo(L-
Phe-trans-4-OH-L-Pro) and δ 2.8 (CD3OD) in cyclo(L-Phe-cis-4-OH-D-Pro). When 
CD3OD is used as solvent for cyclo(L-Phe-trans-4-OH-L-Pro) the effect is even 
more profound and the difference is 1.6 ppm for H-9 (data not shown). In studies 
of cyclo(L-Phe-L-Pro) it has been shown that the phenyl ring stacks over the DKP 
ring (103), which is schematically illustrated in Fig. 10 for both DKPs. When H-9 
is between the two rings, as in cyclo(L-Phe-cis-4-OH-D-Pro), H-9 gets shielded 
compared to when H-9 is outside the rings as in cyclo(L-Phe-trans-4-OH-L-Pro). 
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Fig. 9. 
1H NMR spectrum for a) cyclo(L-Phe-cis-4-OH-D-Pro), CD3OD as solvent and b) 
cyclo(L-Phe-trans-4-OH-L-Pro) DMSO-d6 as solvent, temperature 30 °C for both. H-9 for 
both compounds is indicated in the spectra. 
 
In total, six different DKPs, cyclo(L-Phe-L-Pro) (I, II, IV), cyclo(L-Phe-trans-4-
OH-L-Pro) (I, II), cyclo(L-Phe-cis-4-OH-D-Pro), cyclo(L-Leu-cis-4-OH-D-Pro), 
cyclo(L-Leu-trans-4-OH-L-Pro) (unpublished results) and cyclo(L-Ile-L-Pro) (IV) 
and two fatty acids, (R)-3-hydroxydecanoic acid and 3-hydroxy-5-cis-dodecenoic 
acid (III) and phenyllactic acid (I, II) were characterised using NMR and MS. 
 
 
 
Fig. 10. Schematic structures showing the position of H-9 for a) cyclo(L-Phe-cis-4-OH-D-
Pro) and b) cyclo(L-Phe-trans-4-OH-L-Pro). 
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Mass spectrometry 
In 1912 J. J. Thompson did the pioneering work in mass spectrometry (104). Fifty 
years later the coupling with chromatography was utilised and GC-MS had a huge 
impact on analysing volatiles. In the last two decades MS has been used, often 
together with HPLC, in analysing different biomolecules such as carbohydrates, 
peptides and proteins (105, 106). The applications have moved from physics to 
biology, the same trend as with NMR. 
A mass spectrometer is a device that separates ions based on their mass-to-charge 
ratio (m/z). The basic components of a mass spectrometer are the ion source and 
the mass analyser. The ion sources used in this thesis were electron impact 
connected to GC, electrospray (ES) coupled to HPLC, and fast atom bombardment 
(FAB). 
 
Electron impact was devised by Dempster and further developed by Bleakney & 
Nier (104). In electron impact the sample, in gas phase, is passed through a beam 
of electrons at ~70 eV. The electrons transfer energy to the sample, which results 
in molecular ions, fragment ions and neutral fragments: 
 
M + e
- (~70 eV) → Molecular ions + fragment ions + neutral fragments 
 
Electron impact is well suited to be connected with a gas chromatograph because 
in GC the analytes are in gas phase. The fragmentation pattern that EI creates can 
be used for identification of the analyte. This can be achieved either by studying 
the fragmentations and thereby solving the structure or by using the EI spectrum as 
a fingerprint. Electron impact spectra are to a large extent reproducible and 
therefore can the fingerprint be used for searching in a database, which can lead to 
identification of the analyte. There are many commercially available databases with 
EI spectra. Some of the disadvantages with EI are that the molecular ions are 
seldom observed, EI is limited to volatile and thermally stable molecules (105). 
 
Electrospray was developed in 1984 by Yamashita & Fenn (107, 108). Their 
work was based on the discoveries of Dole and co-workers (109) 16 years earlier, 
when they were able to generate gas-phase ions of macromolecules by spraying a 
solution from the tip of an electrically charged capillary. In ES a diluted sample 
solution is pumped through a high voltage capillary. The voltage can be either 
positive or negative depending on what analytes are studied. The electrospray 
ionisation process is illustrated in Fig. 11. A Taylor cone is created at the capillary 
tip and multiple charged droplets are formed. By using a heated gas, the solvent of 
the droplet evaporates which shrinks the droplet and creates an accumulation of the 
charges in the droplet. This accumulation of charges in the droplet creates an 
explosion. Eventually, smaller droplets are formed, containing a single charged 
molecular ion. 
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Fig. 11. Schematic view of the electrospray ionisation process. 
 
The mechanism of the formation of the single charged molecular ions is not fully 
understood. Today two mechanisms are generally accepted, the charged residue 
model and the ion evaporation model (110-112). Electrospray is a soft ionisation 
technique, which means that almost only molecular ions are detected and thus less 
fragmentation is observed. Electrospray MS is regarded as a rapid, sensitive and 
accurate technique for the determination of biomolecules. Electrospray is suited for 
analysing high molecular weight compounds because in ES multiply charged ions 
can be created. This means that an instrument with a low m/z range can be used to 
analyse high-mass molecules. For a more detailed survey of using ES-MS I 
recommend the article by Cech & Enke (113). The ability to analyse compounds in 
a solution makes ES compatible with separation techniques such as HPLC and CE 
(114). HPLC coupled to ES-MS (115) has been widely applied in chemistry, 
pharmaceutical sciences, natural products research and biochemistry (116-118). 
Disadvantages with ES are difficulties with mixture analysis, the purity of the 
sample is important to avoid ion suppression, and multiple charging and adduct 
formation (Na
+- and K
+- adducts) that can be confusing in the interpretation of the 
spectrum (105). 
 
In the 1980´s Barber and co-workers utilised the MS technique for a study of 
non-volatiles and they opened the field for studies of biomolecules when they 
invented FAB (119-123). In FAB ionisation, the sample is mixed with a non-
volatile liquid matrix, usually glycerol, and deposited on a metal probe. The probe 
is bombarded with a beam of high-energy atoms, usually Xe or Ar. The high-
energy atoms eject sample molecules into the gas phase when crashing on the 
matrix. The sample molecules become charged through reactions with matrix 
molecules or the sample molecules could already be present as ions in the matrix. 
This technique is also a rather soft technique, which gives mostly molecular ions 
and little fragmentation. A disadvantage with this technique is that a high 
background of matrix ions can complicate the detection of the sample molecules in 
the spectrum (105). 
Detailed surveys of EI, ES and FAB and other ionisation techniques, such as 
matrix-assisted laser desorption/ionisation (MALDI), thermospray, plasma 
desorption, atmospheric-pressure chemical ionisation (APCI) and inductively 
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coupled plasma (ICP) can be found in the book by de Hoffmann (104), or in the 
reviews by van Berkel (124) and Vestal (125). 
 
After ions have been formed in the ion source, the ions are analysed in the mass 
analyser. In the mass analyser the ions are separated according to their m/z. There 
are three main characteristics of a mass analyser, the upper mass limit, the 
transmission and the resolution (104). The mass limit determines the highest m/z 
that can be detected, and the transmission is the ratio of how many of the ions 
created in the ion source reach the detector. The resolution is a measurement of the 
ability to separate two distinct signals for two ions with a small difference in m/z. 
The mass analysers that have been used in this thesis are a quadrupole, quadrupole 
ion trap and a four sector (electric sector and magnetic sector + electric sector and 
magnetic sector) tandem mass spectrometer. Other important mass analysers are 
time-of-flight (TOF) and ion cyclotron resonance analysers (104). The quadrupole 
was coupled to a GC with an EI ion source. The quadrupole ion trap instrument 
was coupled to an ES ion source and the instrument had the possibility to perform 
MS
n. The sector instrument was coupled to a FAB ion source and the instrument 
had the possibility to perform MS/MS. Tandem MS (MS/MS) is used to obtain 
structural information about compounds (126),  e.g. sequences of peptides and 
oligosaccharides. In the first MS-stage the molecular ion of interest is isolated and 
then fragmented, usually by using an inert gas (collision-induced dissociation, 
CID). In the second MS-stage the m/z of the fragmentation ions is monitored in a 
so called daughter ion spectrum. In MS
n, which can be done with the quadrupole 
ion trap, further isolation and fragmentation can be performed. This possibility was 
not used in this thesis. The advantages of a sector instrument over the ion trap are 
its higher resolution and accuracy and that high-energy collisions can be used, 
which gives a more complete sequence information. The drawbacks are that the 
sector instrument is big, expensive and more difficult to use (105). 
 
When FAB-MS is used a spectrum with more matrix peaks is generated (Fig. 
12), compared to when ESI-MS is used (Fig. 13). The matrix peaks can complicate 
the interpretation of the spectrum. However, these matrix peaks can be subtracted 
from the spectrum after a blank analysis has been performed. 
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Fig. 12. FAB mass spectrum of standard cyclo(L-Phe-L-Pro) with glycerol as matrix. Matrix 
peaks are marked with *. 
 
For the structure elucidation of cyclo(L-Phe-L-Pro) and cyclo(L-Phe-4-trans-OH-
L-Pro) in paper I, FAB-MS was used, with glycerol as matrix. In paper II ES-MS 
was used for the determination of the molecular weight of the isolated compounds 
from different LAB. 
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Fig. 13. ESI mass spectrum of standard cyclo(L-Phe-L-Pro). F is the immonium ion of Phe. 
 
The investigation of DKPs in MRS medium in paper I was done with HPLC-ES-
MS and is illustrated in Fig. 14. The presence of cyclo(L-Leu-cis-4-OH-D-Pro), 
cyclo(L-Leu-trans-4-OH-L-Pro), cyclo(L-Phe-cis-4-OH-D-Pro), cyclo(L-Phe-trans-
4-OH-L-Pro) and cyclo(L-Phe-L-Pro) was confirmed by comparing retention times   33
(tR) with previously identified DKPs and comparing mass spectra. To verify that 
cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) were produced by the 
bacteria, a defined medium with only amino acids was used for cultivation of L. 
plantarum MiLAB 393 (I). Both cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-
L-Pro) were produced by L. plantarum MiLAB 393 in defined media and it was 
confirmed by isolation and analysis with FAB-MS (I). 
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Fig. 14. Extracted ion chromatogram (EIC) for MRS broth after SPE. Separation was 
performed on a Hypercarb PGC (100 ×  4.6 mm i.d.) under the following conditions: flow 
0.7 ml/min, temp. 50 °C, mobile phase consisted of A; 0.1% formic acid in water and B; 
95% MeCN with 0.1% formic acid and a linear gradient from 40% to 70% B in 30 min and 
0.4 mg sample was injected. 
 
To optimise the HPLC conditions for the HPLC-ES-MS method for DKPs, both 
MeOH and MeCN were tested as organic modifiers together with formic acid or 
TFA. Different temperatures 20-50 °C, and two different column diameters, 4.6 
mm and 2.1 mm, were evaluated. When using a column with a small internal 
diameter, a lower flow rate could be used which is preferable when using ES (127). 
The optimal conditions for best separation and ionisation were MeOH/water and 
0.1% formic acid at 50 °C using the 2.1 mm column. The result of using MeOH 
instead of MeCN as the organic modifier is in agreement with the result of 
Giorgianni  et al ( 128). Giorgianni et al ( 128) reported that MeOH is a better  34
organic modifier than MeCN in LC-MS/MS analysis of peptides. The 
chromatogram for a mixture of five isolated DKPs is shown in Fig. 15. With this 
method we have shown that HPLC-ES-MS, using a PGC column, can be used for 
analysing DKPs. 
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Fig. 15. Chromatogram of five isolated DKPs (0.01–0.001 mg/ml) from LAB (unpublished 
results). Separation was performed on a Hypercarb PGC (100 ×  2.1 mm i.d.) under the 
following conditions: UV-detection at 210 nm, flow 0.4 ml/min, temp. 50 °C, mobile phase 
consisted of A; 0.1% formic acid in water and B; 95% MeOH with 0.1% formic acid and a 
linear gradient from 35% to 100% B in 15 min and 20 µl was injected. 
 
In the determination of peptides from SL medium FAB-MS/MS was used. FAB-
MS/MS is a established method for determination of the amino acid sequences in 
peptides (72, 129-131). The FAB-MS/MS spectrum of Gly-Pro-Phe-Pro-Ile is 
shown in Fig. 16. A differentiation between Leu or Ile could not be achieved from 
the FAB-MS/MS spectra, due to the lack of secondary fragmentation of Leu and 
Ile (wn ions). The wn ions were absent since there was no basic amino acid present 
in the isolated peptides at or near the C-terminus, which seems to be required for 
the formation of wn ions (132). Identification of Leu or Ile was instead done with 
GC-MS, see below. 
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Fig. 16. FAB-MS/MS spectrum of the (M+H)
+ ion (m/z 530.3) of Gly-Pro-Phe-Pro-Ile (V). 
Peaks labelled P and F denotes immonium ions of Pro and Phe. 
 
Absolute configuration 
The need for determination of the absolute configuration of a molecule arises from 
the fact that the spatial arrangements of atoms in a molecule may determine 
important chemical, physical and biological properties of the molecule. The most 
powerful technique for the determination of the absolute configuration of an 
unknown compound is X-ray crystallography. To use X-ray crystallography the 
compound must form crystals, which is often not  the case for natural products. 
Even if crystals can be formed, this might not be enough and a heavy atom has to 
be incorporated into the structure. Other methods that can be used are circular 
dichroism (CD), specific optical rotation, chiral separation or derivatisation of the 
analyte, but all of these methods usually need reference compounds, which are not 
always available. Both CD and optical rotation can be used without reference 
compounds, however this requires a lot of experience. NMR can also be utilised in 
determination of the absolute configuration, either by using derivatisation with a 
chiral agent or analysing the analyte in the presence of a chiral solvent or a chiral 
solvation agent. The former method is the most commonly applied and has recently 
been reviewed by Seco et al  ( 133). For the determination of the absolute  36
configuration of the isolated compounds in this thesis, various sample 
derivatisation methods together with chiral or non-chiral GC-MS were utilised. 
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Fig. 17. Absolute configuration determination of PLA from L. plantarum MiLAB 393 with 
GC-MS using a chiral GC column, for experimental conditions, see paper I. 
 
To determine the absolute configuration of PLA in paper I and IV, a modified 
version of a method for determination of urinary organic acids by Heil et al (134) 
was used. The PLA was analysed as the corresponding methyl ester with GC-MS 
and the two isomers were separated on a chiral GC column. The analysis of PLA 
from L. plantarum MiLAB 393 is shown in Fig. 17. The absolute configuration for 
PLA was determined to be 9 parts L-PLA and 1 part D-PLA. The method did not 
induce any racemisation of the sample because no L-PLA was detected when D-
PLA was analysed (data not shown). In paper IV the absolute configuration of PLA 
from five type strains of PAB was determined and the results, together with the 
result from paper I, have been summarised in Table 5. 
 
Table 5. L/D-PLA ratios determined from propionibacteria and Lactobacillus plantarum 
MiLAB 393 
 
Bacteria  L/D-PLA isomer ratio 
Propionibacterium jensenii   3:2 
P. thoenii 7:3 
P. acidipropionici 2:3 
P. freudenreichii subsp. shermanii 9:1 
P. freudenreichii subsp. freudenreichii 9:1 
L. plantarum MiLAB 393  9:1 
 
There are big differences in the production of L/D isomers of PLA among the 
bacteria. The different PAB also produce different amounts of PLA (IV), e.g. P. 
jensenii produced around 10 times more PLA than P. thoenii. These findings, that 
different PAB produce different ratios of L/D isomers of PLA, could maybe be used 
for identification of PAB.   37
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Fig. 18. GC-MS analysis of a standard mixture of amino acids used for determination of the 
absolute configuration of DKPs isolated from LAB (I, unpublished results). The D isomer 
elutes before the L isomer. For experimental conditions, see paper I. 
 
The absolute configuration of the amino acids of the isolated DKPs and peptides 
was determined using non-chiral GC-MS, after the amino acids had been 
derivatised with (S)-2-butanol (I, IV, V). The sample was first hydrolysed with 6 M 
HCl, then derivatised with (S)-2-butanol to the corresponding ester, followed by an 
amide formation and an ester formation when hydroxyl is present, with 
perfluoropropanoic anhydride. The creation of diastereomers made it possible to 
separate L/D isomers of the amino acids on a non-chiral GC column, because the 
diastereomers have different chemical properties and are hence, possible to 
separate. In Fig. 18 the chromatogram of the standards for L/D-Leu, L/D-Pro, trans-
4-OH-L-Pro, cis-4-OH-D-Pro and L/D-Phe is shown. These reference compounds 
were used for the determination of the absolute configuration of the amino acids in 
the DKPs from P. pentosaceus MiLAB 170 and L. plantarum MiLAB 14 
(unpublished results). One D amino acid, cis-4-OH-D-Pro, was determined from the 
six isolated DKPs and the rest of the amino acids all had the L configuration. 
 
The peptides isolated from the SL medium (V) consisted all of amino acids with 
the L configuration, but the absolute configuration of His could not be determined 
with this method, due to the incompatibility of the His with the GC column. With 
the GC-MS method for absolute configuration of the amino acids we could also 
distinguish Ile from Leu in the isolated peptides and based on the retention times of 
the standards and the MS spectra, the sequence of the isolated peptides was 
completed. 
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Fig. 19. Schematic view, without the stereochemistry, for derivatisation of 3-OH-FAs to 3-
methoxy-FA (S)-phenylethylamide according to Gradowska & Larsson (135). 
 
In paper III the absolute configuration of three 3-hydroxy fatty acids (3-OH FAs) 
from L. plantarum MiLAB 14 was determined using GC-MS. The method was 
developed by Gradowska & Larsson (135) for determination of the absolute 
configuration of 2- and 3-hydroxy fatty acids in organic dust. The absolute 
configuration of the 3-OH FAs was determined by preparation of 3-O-methyl N-
(S)-phenylethylamide derivatives of the 3-OH-FAs, followed by GC-MS analysis 
using a non-chiral GC column. Racemates of 3-OH-decanoic acid, 3-OH-
dodecanoic acid and 3-OH-tetradecanoic acid were used as reference compounds, 
since it has previously been reported that the (R,S) diastereomer of 3-
methoxyphenylethylamides elute earlier than the corresponding (S,S) diastereomer 
(136). A schematic view of the derivatisation procedure, according to Gradowska 
& Larsson (135), of a 3-OH FAs to 3-methoxy-FA (S)-phenylethylamide is shown 
in Fig. 19. The 3-OH-FAs were determined to have the (R) configuration (III). The 
presence of small peaks corresponding to 3-OH-FAs in the (S)-configuration is due 
to racemisation of the sample in the hydrolysis step. The hydrolysis step is shown 
in Fig. 20. It can clearly be seen why racemisation of the sample can occur under 
these conditions. 
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Fig. 20. Racemisation in the hydrolysis step in the derivatisation of 3-OH-FAs to 3-
methoxy-FA (S)-phenylethylamide. 
 
The occurrence of the racemisation was proved by using methanol-d4/D2O, 
instead of using methanol/water in the hydrolysis step (Fig. 21). A sample from L. 
plantarum MiLAB 14 has been hydrolysed using either methanol-d4/D2O or 
methanol/water and the rest of the procedure as shown in Fig. 19. When methanol-
d4/D2O was used as solvent, two protons were replaced with deuterium, hence the 
molecular mass of the final compound was 307, compared to 305 when no protons 
had been exchanged. If racemisation occurred and methanol-d4 was incorporated 
into the molecule, then 50% of the R and 50% of the S isomer would be detected, 
and the molecular mass of the molecule would be 310. From the extracted ion 
chromatogram of ion 310, shown in Fig. 21, it was concluded that a racemisation 
had occurred. To avoid racemisation of the sample we developed a faster and 
simpler method (unpublished results). The method was also based on the analysis 
of a (S)-phenylethylamide derivative, but instead of making an ether of the alcohol, 
the alcohol was trimethylsilylated with the silylating reagent N,O-
bis(trimethylsilyl)trifluoroactamide (BSTFA) and the order of the derivatisations 
was reversed. First, the 3-OH-FA (S)-phenylethylamide was made according to 
Gradowska & Larsson (135) and after that the sample was dissolved in 100 µl 
hexane and 50 µl BSTFA and 10 µl pyridine were added. The sample was heated 
for 60 min at 80 °C and analysed by GC-MS on a fused-silica capillary column 
using a temperature gradient (120-260 °C at 10 °C min
-1, 260 °C for 8 min, injector 
270 °C, interface 270 °C, carrier gas He 1 ml min
-1). The extracted ion 
chromatogram and the mass spectrum for (R)-3-OH-decanoic acid from L. 
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plantarum MiLAB 14 is shown in Fig. 22 and no racemisation was detected. The 
mass spectra for (R)-3-OH-decanoic acid and for the peak after, which should have 
been (S)-3-OH-decanoic acid if a racemisation had occurred, were not identical. 
This result proved that no racemisation had occurred. 
 
In paper III 3-hydroxy-5-cis-dodecenoic acid was also isolated, but due to the 
lack of reference compounds, the absolute configuration of 3-hydroxy-5-cis-
dodecenoic acid could not be determined. 
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Fig. 21. Extracted ion chromatogram (EIC) of derivatised (R)-3-OH-decanoic acid showing 
the incorporation of a) 2 deuterium, Mw = 307 and b) CD3O and two deuterium, Mw 310, 
see text for details. 
 
 
Antifungal metabolites 
There are several reports of antifungal activity from LAB and the literature has 
recently been reviewed by Schnürer & Magnusson (12), but reports of identified 
antifungal metabolites are quite few. The production of the antimicrobial acids 
lactic, propionic and acetic acid from LAB and PAB has been known for a long 
time. Their antifungal effects on several spoilage yeasts and moulds in relation to 
pH have recently been investigated by Lind et al  (137). 
Other identified antifungal metabolites produced by LAB are pentocin TV35b 
(138), 3-hydroxypropionaldehyde (139),  
phenyllactic acid, p-hydroxyphenyllactic acid (I, 140), cyclic dipeptides such as 
cyclo(Gly-L-Leu) (141), cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) 
(I), benzoic acid, 5-methyl-2,4-imidazolidinedione, 4-hydroxy-4-methyl-
tetrahydro-2H-pyran-2-one (141), the aliphatic acids formic, acetic, propanoic, 
butanoic, pentanoic, hexanoic (142) and 3-OH-FAs (III). 
   41
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Fig. 22. a) Extracted ion chromatogram of derivatised (R)-3-OH-decanoic acid from L. 
plantarum MiLAB 14 with novel derivatisation procedure, see text for details. b) Mass 
spectrum for (R)-3-OH-decanoic acid, tR = 14.13 min and c) mass spectrum for the closest 
peak eluating after, tR = 14.28 min.  
 
Investigations of antifungal metabolites from PAB are almost non-existing in the 
literature, except for a few publications on antifungal activity. Schwenninger et al  
(143) have reported antifungal effects from a mixed culture of P. jensenii and 
Lactobacillus paracasei subsp paracasei in yoghurt and cheese, but no metabolites 
were identified, and Meile et al  ( 144) reported several antifungal 
Propionibacterium from the Swiss dairy Propionibacterium  collection. 3-
Phenyllactic acid has been reported to be produced by P. freudenreichii (145, IV). 
In the following chapters I will present the antifungal metabolites that we have 
isolated from LAB and dairy PAB. The isolated and characterised antifungal 
metabolites are shown in Fig. 23. 
 
Diketopiperazines 
Diketopiperazines or cyclic dipeptides, have been known for more than 100 
years, e.g. cyclo(Gly-Gly) was synthesised in 1888 (146). Diketopiperazines are 
common in nature and many DKPs have been isolated through the years (146-148). 
For a detailed survey on DKPs and related compounds I recommend the article by 
Sammes (147). The isolated DKPs from different culture media were for a long 
time regarded as by-products of protein degradation, mainly because many DKPs 
were identified in peptide and protein hydrolysates as well (146). Nevertheless, 
today it is a well-known fact that many microorganisms produce DKPs (146, 148).  42
 
 
 
Fig. 23. Isolated and identified antifungal metabolites from lactic acid bacteria and 
propionic acid bacteria presented in this thesis. 
 
The mechanism for the production of DKPs is not fully understood, but the 
formation of DKPs can be achieved by multifunctional enzymes, non-ribosomal 
peptide synthetases (149) and by single enzyme production (150) from amino 
acids. Diketopiperazines can also be formed from peptides and proteins under 
basic (151) or acidic (152, 153) conditions, e.g. in peptide synthesis, or by 
thermolysis (154, 155). Goolcharran & Borchardt (156) have shown that the 
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formation of DKPs, from a dipeptide, is sensitive to the pH of the solution, the 
buffer species present at high pH, the temperature and the N-terminal amino acid 
residue. Battersby et al  (157) identified cyclo(Phe-Pro) after storage of human 
growth hormone for 4 days, pH 7.4 in 50 °C and at dry state. This indicates a non-
enzymatical degradation of a protein to a DKP under mild conditions. 
Diketopiperazines have been studied in a variety of foods because of their bitter 
taste (154). Several DKPs have been identified in beer (158), chicken essence 
(159), cocoa (154) and roasted coffee (160). During the last 15 years the biological 
activity of DKPs has increased the interest in DKPs (146). Antimicrobial and 
antifungal activities have been reported for cyclo(L-Phe-L-Pro) and three other 
DKPs (161). Brauns et al  (162) and Graz et al  (163) reported anticancer activity 
of cyclo(Phe-Pro). Diketopiperazines have also been identified as signal substances 
in quorum sensing (164-166). Quorum sensing, or auto induction, is a cell-cell 
communication in bacteria accomplished through the exchange of small molecules. 
Most of the quorum sensing systems are species- or group-specific (167). 
 
In this work, several DKPs from LAB and PAB have been isolated (Fig. 23), in 
total six different DKPs have been isolated, and three of them have not been 
reported before. In Table 6 the literature data for the isolated DKPs in this work 
are summarised, showing their origin and biological activity. 
 
None of the isolated DKPs were synthesised by us. For a comprehensive 
literature survey on the synthesis of DKPs I recommend the review by Fischer 
(179). Two DKPs were purchased, cyclo(L-Phe-L-Pro) and cyclo(L-Ile-L-Pro), and 
their antifungal activity were evaluated (I, IV). The minimal inhibitory 
concentration (MIC) for cyclo(L-Phe-L-Pro) was determined to be 20 mg/ml at pH 
4 against A. fumigatus and P. roquerforti  (I) and 20 mg/ml for cyclo(L-Ile-L-Pro) 
against A. fumigatus (IV). When combining 5 mg/ml of PLA with 10 mg/ml of 
cyclo(L-Phe-L-Pro) total inhibition was detected, revealing possible synergistic 
effects (I). The identified antifungal activity of cyclo(L-Phe-L-Pro) is quite 
moderate when compared to antifungal drugs, e.g. amphotericin B had a MIC of 1 
µg/ml at pH 5.5 and for nikkomycin Z the MIC was 512 µg/ml at pH 7.0 (180). 
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Table 6. Reported sources and activities of the isolated diketopiperazines in this thesis 
 
Diketopiperazine Source  Activity  Reference 
Cyclo(L-Phe-L-Pro) 
 
 
 
 
 
 
 
Lactobacillus plantarum MiLAB 393 
L. coryniformis Si3 
L. plantarum MiLAB 14 
Pseudomonas aeruginosa 
P. putida 
Cyphomyrmex minutus 
Sponge 
Bacillus isolate 
Streptomyces 
Propionibacterium jensenii 
Propionibacterium thoenii 
 
Antifungal 
Antifungal 
Antifungal 
Antimicrobial 
Quorum sensing 
Antifungal 
- 
Antimicrobial 
Antimicrobial, antifungal 
Antifungal 
Antifungal 
I 
II 
II 
168 
165 
169 
170 
171
a 
172 
IV 
IV 
Cyclo(L-Phe-trans-4-
OH-L-Pro) 
L. plantarum MiLAB 393 
L. coryniformis Si3 
Marine bacterium 
Pseudoalteromonas luteoviolacea 
Jaspis digonoxea (sponge) 
Sponge 
 
Antifungal 
Antifungal 
Plant growth promotion 
Stimulate antibiotic prod. 
- 
- 
I 
II 
173 
174 
175 
176 
Cyclo(L-Phe-cis-4-
OH-D-Pro) 
Pediococcus pentosaceus MiLAB 170 
L. plantarum MiLAB 14 
Aureobasidium pullulans 
 
Antifungal 
Antifungal 
- 
Unpublished result 
Unpublished result 
177 
Cyclo(L-Leu-trans-4-
OH-L-Pro) 
P. pentosaceus MiLAB 170 
L. plantarum MiLAB 14 
Marine bacteria 
Rabbit skin 
 
Antifungal 
Antifungal 
Plant growth promotion 
Plant growth regulator 
Unpublished result 
Unpublished result 
173 
178 
Cyclo(L-Leu-cis-4-
OH-D-Pro) 
P. pentosaceus MiLAB 170 
A. pullulans 
 
Antifungal 
- 
Unpublished result 
177 
Cyclo(L-Ile-L-Pro)  P. jensenii 
P. aeruginosa 
Antifungal 
Antimicrobial 
IV 
168 
a No absolute configuration was determined. 
 
 
3-Phenyllactic acid 
3-Phenyllactic acid can be produced by bacteria from p-hydroxyphenylpyruvic acid 
(181), or from phenylpyruvic acid (182). 3-Phenyllactic acid is also a part of 
phenylalanine metabolism, which has been reported for LAB (183, 184), PAB 
(145) and rumen bacteria (185) where Phe has been described to be transformed to 
phenylpyruvic acid, which was further, metabolised to PLA (186-188). The 
possible metabolic pathways for PLA from Phe or p-hydroxyphenylpyruvate are 
shown in Fig. 24.   45
 
 
Fig. 24. Possible metabolic pathways for PLA by bacteria. 
 
3-Phenyllactic acid has been reported from several microorganisms (Table 7). 
Antimicrobial activity for D-PLA (190-192) against both Gram-positive and Gram-
negative bacteria has been reported, and a broad antifungal activity has also been 
reported for PLA (192). Literature data of MIC against fungi for PLA is in the 
range of 3.75 – 7.5 mg/ml (192). In paper I MIC of PLA against A. fumigatus was 
determined to 7.5 mg/ml. From our findings and from the literature it can be 
concluded that a large number of LAB and propionibacteria have the ability to 
produce the antifungal metabolite PLA. 
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Table 7. Microorganisms that produce 3-phenyllactic acid 
 
Compound Microorganism  Reference 
Phenyllactic acid  Lactobacillus plantarum MiLAB 393 
L. coryniformis Si3 
L. plantarum MiLAB 14 
L. plantarum 
L. rhamnosus 
L. alimentarius 
L. fermentum 
L. sanfranciscensis 
L. acidophilus 
L. brevis 
L. hilgardii 
Weissella confusa 
Enterococcus faecium 
Leuconostoc mesenteroides 
L. citreum 
Geotrichum candidum 
Propionibacterium jensenii 
P. thoenii 
P. acidipropionici 
P. freudenreichii subsp. shermanii 
P. freudenreichii subsp. freudenreichii 
P. freudenreichii 
I 
II 
Unpublished result 
140 
184 
184 
184 
184 
184 
184 
184 
184 
184 
184 
184 
189 
IV 
IV 
IV 
IV 
IV 
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Hydroxy fatty acids 
Hydroxy fatty acids are abundant in plants, animals and fungi (193, 194). In 
bacteria OH-FAs can be present in lipopolysaccharides (195) or in poly-
hydroxyalkanoic acids (196). On the other hand, Gram-positive bacteria, such as 
LAB, have no lipopolysaccharides and there are no reports on 
polyhydroxyalkanoic acids from LAB. Fatty acids from LAB in fermented milk 
have been reported by Rao & Reddy (197) and cellular FAs, mainly saturated and 
monounsaturated FAs, have been used for the classification of LAB (198-200), but 
reports on OH-FAs from LAB are few. However, Lee et al  (201) identified 2-
hydroxyhexadecanoic acid and 3-hydroxyheptadecanoic acid from different 
Leuconostoc strains. Reports have shown that LAB can metabolise unsaturated 
FAs into OH-FAs (202, 203) indicating metabolic pathways for the hydroxylation 
of FAs, however the exact role of 3-OH-FAs in LAB metabolism remains to be 
elucidated. 
 
There are several reports on biological activity for FAs, e.g. antifungal (204-206) 
and antimicrobial activity (207-210). However, there are only a few reports on 
biological activity for OH-FAs, antifungal (211, 212), antiviral (213) and 
antimicrobial activities (214) for OH-FAs. 
 
The antifungal saturated 3-OH-FAs and 3-hydroxy-5-cis-dodecenoic acid from 
L. plantarum MiLAB 14 (III) are presented in Fig. 23. All 3-OH-FAs have 
previously been isolated and reported, 3-hydroxydecanoic acid from ant (215), 
milk (216) and from lake sediment (217). 3-Hydroxydodecanoic and 3-  47
hydroxytetradecanoic acid have also been isolated from milk (216) and lake 
sediment (217), while 3-hydroxy-5-cis-dodecenoic acid has been isolated from 
Serratia marcescencs (218), without determination of the absolute configuration, 
and from Phytium ultimum (101). The identified saturated 3-OH-FAs were potent 
against a broad spectrum of yeast and moulds (III). The MIC values for the 
compounds were in the range of 10 – 100 µg/ml. The MIC for 3-
hydroxytetradecanoic acid could not be determined due to the low solubility in 
water. These values show that 3-OH-FAs are much more potent than PLA and 
DKPs, and almost as potent as antifungal drugs (180). 
 
 
Antifungal compounds in the growth medium 
In the search for antifungal metabolites from microorganisms cell-free supernatant 
of microorganism grown in a liquid medium is often analysed. The growth medium 
is usually quite complex and the content is not fully characterised. The broth used 
for LAB in papers I-III was MRS broth (219), which contains undefined 
compounds from yeast extract, a peptic digest of meat proteins (peptone) and a 
meat extract (Lab-Lemco). Thus, the medium itself might contain several 
compounds with antifungal properties. Therefore, it is very important to evaluate 
the growth medium separately as well as with the bacterium present. In 2002 there 
were two reports that identified acetic acid in MRS medium as an antifungal agent, 
which contributed to the antifungal activity in the presence of LAB (220, 221). In 
our studies of LAB (I-III) we had no problems with acetic acid from the MRS, 
because we used two fractionation steps, SPE and HPLC, before we investigated 
the antifungal activity. Hence, no acetic or lactic acid was present in the fractions 
with activity (II). All of the DKPs isolated from LAB presented in this thesis (I-III, 
unpublished results) were also detected in the MRS broth. However, the fractions 
that correspond to the DKPs had no activity when the MRS broth was analysed (I). 
In paper I we showed that L. plantarum MiLAB 393 produced the isolated DKPs 
when the bacterium was cultivated in a defined medium (222) that only contained 
amino acids. The defined medium was analysed with the HPLC-ESI-MS method 
for DKPs, described above, and no DKPs were detected (data not shown). 
 
The medium used for cultivation of propionibacteria was an SL medium (137), 
which contained undefined compounds from yeast extract and from a pancreatic 
digest of casein (tryptone). Casein is the main protein of milk. During the study of 
five type strains of PAB (IV) several antifungal peptides were isolated (V). In total, 
seven peptides were isolated and characterised by FAB-MS/MS (Table 8). All 
these peptides were detected in the SL medium (V) and were thus not produced by 
the bacteria.   48
 
Table 8. Antifungal peptides identified in SL medium and their possible origin (V) 
 
Molecular mass  Sequence  Posssible origin 
575 His-Pro-Leu-Pro-Leu  Unknown 
635 Phe-Leu-Pro-Tyr-Pro  Casein 
529 Gly-Pro-Phe-Pro-Ile  Casein 
529 Gly-Pro-Phe-Pro-Leu 
 
Unknown 
628 Gly-Pro-Phe-Pro-Leu-Val  Unknown 
889 Val-Tyr-Pro-Phe-Pro-Gly-Pro-Ile 
 
Casein 
963 Val-Ala-Pro-Phe-Gly-Val-Ala-Val-Phe-Gly  Unknown 
 
The activity of the peptides was low and the MIC values were > 10 mg/ml (V). 
The exact values for the MIC determination were not investigated because of the 
low antifungal potency of the peptides. Three of the seven peptides, Gly-Pro-Phe-
Pro-Ile (223, Swiss-Prot no.: P02666), Phe-Leu-Pro-Tyr-Pro (224, Swiss-Prot no.: 
P02668) and Val-Tyr-Pro-Phe-Pro-Gly-Pro-Ile (223, Swiss-Prot no.: P02666) 
could originate from the casein in the medium. This was determined by comparing 
the protein sequence for casein (223, 224) with the sequences of the isolated 
peptides. The other peptides did not match any of the protein sequences for casein 
or for Saccharomyces cerevisiae, and therefore the origin of the other peptides 
could not be determined (V). One of the peptides, Gly-Pro-Phe-Pro-Ile from 
casein, has previously been isolated and reported to inhibit cathepsin B (225). 
None of the other peptides have previously been isolated or characterised. 
 
 
Conclusions and future perspectives 
In this thesis several antifungal strains of LAB and strains of dairy propionibacteria 
have been studied and in total twelve antifungal metabolites have been 
characterised (I – IV, unpublished results). The compounds were low-molecular 
weight compounds and the majority of them have never before been reported to be 
produced by LAB or PAB. 
 
In Paper I a method for isolating and characterising antifungal metabolites was 
reported. The methodology of using bioassay-guided fractionation is not new, 
however the combination of fungal bioassay and the use of modern separation 
techniques, has not been used previously for the study of metabolites from LAB 
and propionibacteria. A patent application was filed concerning the use of L. 
plantarum MiLAB 393 in the preservation of straw or green fodder (226) and the 
right to use it has been purchased by Medipharm AB. Medipharm AB has 
developed a biopreservative product, Feedtech 3000
®, containing L. plantarum 
MiLAB 393 (Kerstin Holmgren, Medipharm AB, personal communication) that 
will be launched in Europe this year. 
 
In paper II, several LAB strains were also shown to produce PLA, cyclo(L-Phe-
L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and from P. pentosaceus MiLAB 170   49
additional DKPs were isolated and characterised (unpublished results). The most 
potent compounds isolated from LAB were 3-OH-FAs, which were identified from 
L. plantarum MiLAB 14 (III). This strain of L. plantarum also produced several 
DKPs and PLA (unpublished results). 
 
An HPLC-ESI-MS method for the determination of DKPs was developed 
(unpublished results) and used for the detection of DKPs in MRS medium (I) and 
SL medium (IV). However, the amounts of DKPs in the cultivation media were not 
enough for inhibition of A. fumigatus. In paper I we showed that L. plantarum 
MiLAB 393 produced DKPs when we used a defined medium without any DKPs 
present. 
 
An existing GC-MS method for the determination of the absolute configuration 
of 2- and 3-OH-FAs was shown to racemise the sample slightly (5%) during the 
sample derivatisation (I). The method was modified so that no racemisation would 
occur (unpublished results). 
 
In paper IV the production of antifungal metabolites from the type strains of five 
dairy propionibacteria species was studied. The production of PLA was 
investigated and, surprisingly, four of the propionibacteria produced PLA at 
different  L/D-isomer ratios. The two DKPs that were isolated and characterised 
were cyclo(L-Phe-L-Pro) and cyclo(L-Ile-L-Pro), the latter DKP has not been 
isolated previously by us, and none of the isolated DKPs have previously been 
reported to be produced by propionibacteria. 
 
In paper V we investigated the antifungal compounds present in the SL medium. 
Some of the active fractions were active against many different fungi and from 
these fractions seven antifungal peptides were isolated and characterised. The most 
potent peptide was His-Pro-Leu-Pro-Leu, which inhibited A. fumigatus at the same 
concentration as cyclo(L-Phe-L-Pro) (I) and cyclo(L-Ile-L-Pro) (IV). 
 
For many years the pharmaceutical industry has been screening natural products 
for potential drug compounds. During the period 1981–2002, 49% of all new 
chemical entities was derived, isolated from or in other ways related to metabolites 
from a natural product (227). However, in the last decade many pharmaceutical 
companies have downsized their research of natural products (228, 229). I hope 
that this thesis has shown some of the possibilities that microorganisms, in this 
study LAB and PAB, offer. The use of microorganisms in agriculture, forestry and 
food industry has a great potential. However, a lot of research is needed: 
 
•  Investigation of microorganisms and determination of active metabolites 
against e.g. fungi, bacteria, viruses and cancer has to continue. 
•  Studies of the mechanism and the mode of action for microorganisms and 
their active metabolites. 
•  Investigation of possible synergistic effects between active metabolites 
produced,  e.g. synergistic effects between the DKPs, lactic acid, 
phenyllactic acid and 3-OH-FAs produced by L. plantarum MiLAB 14.  50
•  Evaluation of the possibility of using one or several of the studied bacteria 
in food and feed systems. 
•  In vivo studies to investigate if the evaluated antifungal LAB and 
propionibacteria strains in this thesis are active in vivo and produce 
antifungal metabolites. 
•  In vivo studies to investigate if there are negative effects, and in that case, 
the nature of those negative effects when using microorganisms in vivo. 
   51
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